Results 151 to 160 of about 693 (192)

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source

[Toxic hepatitis after flutamide treatment]. [PDF]

Aten Primaria, 2005
Bengoechea Gallastegui L, Vita Garay A, Castiella Eguzkiza A, Egido Arroyo JF.   +3 more
europepmc   +1 more source

Análise da hepatotoxicidade do paracetamol

, 2023
openaire   +2 more sources

Cutaneous leishmaniasis: immunological insights and clinical challenges. [PDF]

Colomb Med (Cali)
Serrano-Coll H, Aristizábal-Parra LK, Olarte G, Salamanca-Leguizamón C.   +3 more
europepmc   +1 more source

[Impact of P-CABs in the Treatment of Acid-related Diseases: an Evidence Review]. [PDF]

Acta Gastroenterol Latinoam
Remes-Troche JM, Vargas-Basurto JL, Valdovinos-García L.   +2 more
europepmc   +1 more source

Hepatotoxicidade induzida pelos tuberculostáticos

, 2012
openaire   +2 more sources

Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study. [PDF]

Rev Peru Med Exp Salud Publica
Ccami-Bernal F, Rojas-Miliano C, Soriano-Moreno DR, Fernández-Guzmán D, Quispe-Vicuña C, Hernández-Bustamante EA, Zamora-Huaringa EG, Nieto-Gutiérrez W.   +7 more
europepmc   +1 more source